Owens Illinois has put on hold the sale of its Australasian business. This business is a key competitor to ORA in glass bottles. A dispirited competitor should be good for ORA.
In these uncertain times customers are looking for well managed suppliers and here ORA May have an opportunity to pick up market share in a key sector.
- Forums
- ASX - By Stock
- ORA
- Key Competitor Sale on Hold
ORA
orora limited
Add to My Watchlist
0.00%
!
$2.31

Key Competitor Sale on Hold
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.31 |
Change
0.000(0.00%) |
Mkt cap ! $2.959B |
Open | High | Low | Value | Volume |
$2.32 | $2.33 | $2.27 | $6.598M | 2.861M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 16533 | $2.29 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.32 | 17728 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 15533 | 2.290 |
2 | 3800 | 2.280 |
1 | 2000 | 2.240 |
1 | 1800 | 2.230 |
2 | 40000 | 2.210 |
Price($) | Vol. | No. |
---|---|---|
2.320 | 17728 | 4 |
2.330 | 18500 | 3 |
2.340 | 420 | 1 |
2.350 | 23560 | 3 |
2.360 | 74500 | 6 |
Last trade - 16.19pm 21/08/2025 (20 minute delay) ? |
Featured News
ORA (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, MD & CEO
Michael Thurn
MD & CEO
SPONSORED BY The Market Online